Search Results 911-920 of 18322 for Hepatitis b

1. Baricitinib in Relapsing Giant Cell Arteritis - Mayo Clinic

   Positive for hepatitis B surface antigen (HBsAg), or; Positive for anti-hepatitis B core antibody (HBcAb) If any of the Hepatitis B tests have an ...

2. Rifampin, isoniazid, and pyrazinamide (oral route) - Side effects & dosage - Mayo Clinic

   There may be an increased chance of getting liver problems (eg, hepatitis) if you take this medicine and drink alcohol daily. Gout, acute or; Liver disease ...

3. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

   ... b/c\]), or T3 to T4 due to multiple lung nodules that are too extensive or ... hepatitis C infection (participants with hepatitis C that achieve a ...

4. 6 Mayo Clinic researchers selected for Diversity in Clinical Trials Career Development Award

   ... hepatitis B- and C-induced hepatocellular carcinoma, a special at-risk population that is underrepresented in immunotherapy trials, yet could derive immense ...

5. Publications - Konstantinos N. Lazaridis, M.D. - Mayo Clinic

   ... B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU ... Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption. ... Environmental risk factors are ...

6. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

   Seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Subjects with resolved infection (i.e., subjects who are ...

7. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

   active Hepatitis B or Hepatitis C. Antiviral prophylaxis for chronic Hepatitis B virus infection may be used at the discretion of the investigator.

8. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

   * Has a positive serologic test for human immunodeficiency virus (HIV), hepatitis B virus surface antigen, or hepatitis C virus. * Previous participation in ...

9. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Patients with active hepatitis B (chronic or acute; defined as having a positive hepatitis B surface antigen [HBsAg] test at screening) or hepatitis C:.

10. Publications - P. Pearse P. Morris, M.B., B.Ch. - Mayo Clinic

    Madhavan AA, Lutzen N, Cutsforth-Gregory JK, Schievink WI, Kodet ML, Mark IT, Morris PP, Messina SA, Wald JT, Brinjikji W. Additional Diagnostic Value of ...